The burgeoning popularity of retatrutide, initially for diabetes , is creating significant attention within the British Isles, prompting a notable shift in medication trends. Availability these compounds remains a complex challenge , with NHS provision currently limited and private clinics offering therapy at a premium . Concerns are being raised r